Proper Level of Lipid Lowering with Pitavastatin and Ezetimibe in Acute Coronary Syndrome

Trial Profile

Proper Level of Lipid Lowering with Pitavastatin and Ezetimibe in Acute Coronary Syndrome

Completed
Phase of Trial: Phase IV

Latest Information Update: 18 Apr 2017

At a glance

  • Drugs Ezetimibe (Primary) ; Pitavastatin (Primary)
  • Indications Acute coronary syndromes
  • Focus Biomarker; Therapeutic Use
  • Acronyms HIJ-PROPER
  • Most Recent Events

    • 18 Apr 2017 Primary endpoint (Occurrence of any of the composite cardiovascular events) has not been met.
    • 18 Apr 2017 Results published in the European Heart Journal
    • 16 Nov 2016 Status changed from active, no longer recruiting to completed.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top